Akretive Holdings LLC - 30 Oct 2026 Form 3 Insider Report for cbdMD, Inc. (YCBD)

SEC form
3
Accepted by SEC
04 Nov 2026, 19:15:20 UTC
Source filing
View source filing
Filing notes and source

Key filing fact

Akretive Holdings LLC filed Form 3 for cbdMD, Inc. (YCBD) on 04 Nov 2026.

Key facts

  • This page summarizes Akretive Holdings LLC's Form 3 filing for cbdMD, Inc. (YCBD).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Nov 2026, 19:15.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001655238 Primary reporting owner

Akretive Holdings LLC

Relationship
10%+ Owner

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

YCBD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,229,805
Date
30 Oct 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Reporting Person acquired the shares pursuant to an Asset Purchase Agreement dated September 1, 2026, by and among the Issuer, To Be Brands, LLC, Twinlab Consolidated Holdings, Inc., Twinlab Consolidated Holdings, Inc., Philip J. Von Kahle, in his capacity as the duly appointed assignee, and the Reporting Person effective October 30, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .